Genetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer's disease
- PMID: 16865098
- DOI: 10.1038/sj.tpj.6500383
Genetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer's disease
Comment on
-
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease.Pharmacogenomics J. 2006 Jul-Aug;6(4):246-54. doi: 10.1038/sj.tpj.6500369. Epub 2006 Jan 31. Pharmacogenomics J. 2006. PMID: 16446752 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
